Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype

Leuk Lymphoma. 2019 Aug;60(8):2025-2033. doi: 10.1080/10428194.2018.1551535. Epub 2019 Jan 16.

Abstract

Germline mutations in GATA2 are associated with a complex immunodeficiency and cancer predisposition syndrome. Somatic GATA2mut in myeloid malignancies may impart a similar phenotype. We reviewed adult patients with a diagnosis of GATA2mut hematological malignancy who were referred to our HHMC for genetic testing, and identified to have somatic GATA2mut. Nine patients with a median age of 63 years were included. Six patients (66.7%) were males. Atypical CML and acute myeloid leukemia were the most common initial presentation. The median overall VAF was 47.14%. Monocytopenia was pronounced when the GATA2mut involved the C-terminal ZFD. GATA2 N-terminal ZFD mutations tend to be co-mutated with biCEBPAmut. Unlike germline GATA2 mutations, monocytopenia associated with somatic GATA2 mutations often resolved at remission. We concluded that similar to germline GATA2 mutations, a subset of somatic GATA2 mutations can impart a germline phenotype.

Keywords: Emberger syndrome; GATA2; MonoMAC syndrome; immunodeficiency; pulmonary alveolar proteinosis.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Alleles
  • Disease Management
  • Female
  • Flow Cytometry
  • GATA2 Transcription Factor / genetics*
  • GATA2 Transcription Factor / metabolism
  • Gene Expression
  • Genetic Association Studies
  • Genetic Predisposition to Disease*
  • Genotype
  • Germ-Line Mutation
  • Hematologic Neoplasms / complications
  • Hematologic Neoplasms / diagnosis
  • Hematologic Neoplasms / genetics
  • Hematologic Neoplasms / immunology
  • Humans
  • Leukocyte Count
  • Male
  • Middle Aged
  • Mutation*
  • Myeloproliferative Disorders / complications*
  • Myeloproliferative Disorders / diagnosis
  • Myeloproliferative Disorders / genetics*
  • Myeloproliferative Disorders / immunology
  • Phenotype*
  • Primary Immunodeficiency Diseases / diagnosis*
  • Primary Immunodeficiency Diseases / etiology*
  • Primary Immunodeficiency Diseases / mortality
  • Primary Immunodeficiency Diseases / therapy
  • Prognosis
  • Young Adult

Substances

  • GATA2 Transcription Factor
  • GATA2 protein, human